Butterfly Sensor With Rev K Version
NCT01992003 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 9
Last updated 2015-04-09
Summary
The primary purpose of this study is to assess the accuracy of the newly released Masimo SpHb Butterfly Sensor with RevK version and compare the results to a blood hemoglobin level analyzed in the UCSF Clinical Laboratories. A secondary purpose is to assess the blood hemoglobin using the Masimo Pronto-7 hand-held device immediately prior to surgery.
Conditions
- Blood Loss
Sponsors & Collaborators
-
University of California, San Francisco
lead OTHER
Principal Investigators
-
Ronald D Miller, MD · University of California, San Francisco
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- United States
Study Locations
More Related Trials
-
Development of Kinetic Biomarkers of Liver Fibrosis Measuring NAFLD
NCT02124577 ·Status: UNKNOWN
-
Pancreas Cancer Surveillance Using an Abbreviated MRI
NCT04592393 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Trans-Hepatic Flow Changes in Major Hepatectomy
NCT03762876 ·Status: UNKNOWN
-
Non-invasive Quantification of Liver Iron With MRI
NCT02425956 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
NCT02550613 ·Status: UNKNOWN
-
Controlled Low Central Venous Pressure Combined With Hilar Block in Laparoscopic Hepatectomy
NCT03422913 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Preoperative Hemotologic Markers on Postoperative Long-term and Short-term Outcomes for Laparoscopic Gastrectomy
NCT02930278 ·Status: UNKNOWN
-
LEAF (Liver Tumor dEtection And classiFication AI)
NCT06859840 ·Status: RECRUITING ·Phase: NA
-
Observational Study of Biomarker During Liver Surgery
NCT02102971 ·Status: TERMINATED
-
Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma
NCT03285867 ·Status: UNKNOWN
-
The Utility of Cell-free Methylation Markers in Blood for Hepatocellular Carcinoma
NCT05576571 ·Status: UNKNOWN
-
Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content
NCT02025543 ·Status: COMPLETED
-
Liver and Biliary Tumor Tissue Registry
NCT02917759 ·Status: TERMINATED
-
LS301 Uptake in Tumors of Patients Undergoing Liver, Pancreas, or Gastric Surgery
NCT04105062 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
NCT03894917 ·Status: RECRUITING
-
Accuracy and Reliability of GSA for Remnant Liver Function
NCT02013895 ·Status: AVAILABLE
-
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
NCT03213314 ·Status: COMPLETED ·Phase: NA
-
Examination the Ability to Early Diagnose HCC by Combining Three Biomarkers Technology Developed by WAKO, And Their Relevance to Cirrhotic of Patients With Various Backgrounds and the Israeli Population.
NCT02826005 ·Status: UNKNOWN ·Phase: NA
-
mSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis
NCT06778317 ·Status: RECRUITING
-
Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring
NCT06005883 ·Status: COMPLETED
-
Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients
NCT02587793 ·Status: COMPLETED
-
Energy Expenditure and Regeneration Following Liver Resection Resection
NCT02031094 ·Status: COMPLETED
-
Ga-68 Dolacga PET Scan in HCC Under RFA
NCT06792097 ·Status: NOT_YET_RECRUITING
-
Efficacy of HIFU-AR on Blood Loss Reduction in Patients With Liver Metastases Requiring Hepatectomy
NCT02728167 ·Status: TERMINATED ·Phase: NA
-
Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis
NCT01342705 ·Status: TERMINATED ·Phase: PHASE3